Skip to content

The Study of of Risk Factors for Conversion of Rapid Eye Movement Sleep Behavior Disorder

The Study of Risk Factors for Conversion of Idiopathic Rapid Eye Movement Sleep Behavior Disorder to Synucleinopathies

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016984
Enrollment
Unknown
Registered
2018-07-05
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rapid eye movement sleep behavior disorder

Interventions

Case series:Nil

Sponsors

Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) iRBD diagnosised by vPSG; 2) aged between 45 and 75 years old; 3) with verifiable medical history, such as past medical history, family history, etc..

Exclusion criteria

Exclusion criteria: 1) With sign of dementia; 2) With history of intracranial surgery or traumatic brain injury, no psychiatric disorders; 3) With signs of depression, g) no history of severe eye disease (apply to oculomotor examination); 4) With history of other neurological disorders, such as encephalitis, cerebral infarction, etc.; 5) With metal implantation (apply to fMRI examination), not allergic to contrast agents; 6) with no rheumatism history, with no chronic or acute inflammation; 7) With alcoholism.

Design outcomes

Primary

MeasureTime frame
RBD Screening Questionnaire score;Movement Disorders Society Unified Parkinson's Disease rating scale, MDS-UPDRS score;Chinese version of the Mini-Mental State Examination, cMMSE score;Montreal Cognitive Assessment, Moca score;17-item Hamilton Depression Rating Scale, HAMD-17 score;Sniffin Sticks 16-item test, SS-16 score;non motor symptoms questionnaire,NMSQ score;Scale for Outcomes in PD-Autonomic, SCOPA-AUT score;ability of visual tracking;signal value of functional connectivity;ability of upper extremities motor function;ability of gait controlling;uptake of dopamine transporter in basal ganglia;uptake of 18F-FDOPA in basal ganglia;uptake of 18F-FPCIT in basal ganglia;

Countries

China

Contacts

Public ContactJun Liu

Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine

jly0520@hotmail.com+86 15221303819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026